Boxer Capital caters to public companies based in the biotechnology industry.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 31, 2022
Incyclix Bio
|
Series B | $30M | Biotechnology | Yes |
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | Yes |
Dec 5, 2019
Black Diamond Therapeutics
|
Series C | $85M | Biotechnology | Yes |
Sep 4, 2019
Passage Bio
|
Series B | $110M | Biotechnology | — |
Jan 9, 2019
Black Diamond Therapeutics
|
Series B | $85M | Biotechnology | Yes |